Provider of medicinal chemistry as-a-service powered by machine learning. The company designs and synthesizes molecules faster and at a lower cost, using machine learning to optimize the entire molecular design process and computational tools suggests new scaffolds, predict the success of chemical reactions, and design new synthetic routes to challenging molecules, enabling customers to fast-track drug discovery.
Total Funding: $26.5 M
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2019
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at PostEra
